FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2801858894> ?p ?o ?g. }

• W2801858894 abstract "Melanoma brain metastasis is associated with an extremely poor prognosis, with a median overall survival of 4–5 months. Since 2011, the overall survival of patients with stage IV melanoma has been significantly improved with the advent of new targeted therapies and checkpoint inhibitors. We analyze the survival outcomes of patients diagnosed with brain metastasis after the introduction of these novel drugs. We performed a retrospective analysis of our melanoma center database and identified 79 patients with brain metastasis between 2011 and 2015. The median time from primary melanoma diagnosis to brain metastasis was 3.2 years. The median overall survival duration from the time of initial brain metastasis was 12.8 months. Following a diagnosis of brain metastasis, 39 (49.4%), 28 (35.4%), and 24 (30.4%) patients were treated with anti-CTLA-4 antibody, anti-PD-1 antibody, or BRAF inhibitors (with or without a MEK inhibitor), with a median overall survival of 19.2 months, 37.9 months and 12.7 months, respectively. Factors associated with significantly reduced overall survival included male sex, cerebellar metastasis, higher number of brain lesions, and treatment with whole-brain radiation therapy. Factors associated with significantly longer overall survival included treatment with craniotomy, stereotactic radiosurgery, or with anti-PD-1 antibody after initial diagnosis of brain metastasis. These results show a significant improvement in the overall survival of patients with melanoma brain metastasis in the era of novel therapies. In addition, they suggest the activity of anti-PD-1 therapy specifically in the setting of brain metastasis." @default.
• W2801858894 created "2018-05-17" @default.
• W2801858894 creator A5005421990 @default.
• W2801858894 creator A5011254949 @default.
• W2801858894 creator A5015498468 @default.
• W2801858894 creator A5019366279 @default.
• W2801858894 creator A5033513252 @default.
• W2801858894 creator A5036760030 @default.
• W2801858894 creator A5051508940 @default.
• W2801858894 creator A5060100321 @default.
• W2801858894 creator A5066416832 @default.
• W2801858894 creator A5076261158 @default.
• W2801858894 creator A5079717318 @default.
• W2801858894 creator A5088848843 @default.
• W2801858894 creator A5091716304 @default.
• W2801858894 date "2018-04-27" @default.
• W2801858894 modified "2023-09-27" @default.
• W2801858894 title "Survival and clinical outcomes of patients with melanoma brain metastasis in the era of checkpoint inhibitors and targeted therapies" @default.
• W2801858894 cites W1509074660 @default.
• W2801858894 cites W1917632054 @default.
• W2801858894 cites W1951090871 @default.
• W2801858894 cites W1965370740 @default.
• W2801858894 cites W1968221752 @default.
• W2801858894 cites W2015457060 @default.
• W2801858894 cites W2027567030 @default.
• W2801858894 cites W2067893090 @default.
• W2801858894 cites W2070259449 @default.
• W2801858894 cites W2091100650 @default.
• W2801858894 cites W2103220202 @default.
• W2801858894 cites W2109513968 @default.
• W2801858894 cites W2121545342 @default.
• W2801858894 cites W2152897456 @default.
• W2801858894 cites W2160379492 @default.
• W2801858894 cites W2160766792 @default.
• W2801858894 cites W2166478145 @default.
• W2801858894 cites W2166662937 @default.
• W2801858894 cites W2181592619 @default.
• W2801858894 cites W2295218932 @default.
• W2801858894 cites W2482589824 @default.
• W2801858894 cites W2560367415 @default.
• W2801858894 cites W2572174216 @default.
• W2801858894 cites W2620651944 @default.
• W2801858894 cites W2890815045 @default.
• W2801858894 cites W4376595583 @default.
• W2801858894 cites W3145072907 @default.
• W2801858894 doi "https://doi.org/10.1186/s12885-018-4374-x" @default.
• W2801858894 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5924486" @default.
• W2801858894 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29703161" @default.
• W2801858894 hasPublicationYear "2018" @default.
• W2801858894 type Work @default.
• W2801858894 sameAs 2801858894 @default.
• W2801858894 citedByCount "71" @default.
• W2801858894 countsByYear W28018588942019 @default.
• W2801858894 countsByYear W28018588942020 @default.
• W2801858894 countsByYear W28018588942021 @default.
• W2801858894 countsByYear W28018588942022 @default.
• W2801858894 countsByYear W28018588942023 @default.
• W2801858894 crossrefType "journal-article" @default.
• W2801858894 hasAuthorship W2801858894A5005421990 @default.
• W2801858894 hasAuthorship W2801858894A5011254949 @default.
• W2801858894 hasAuthorship W2801858894A5015498468 @default.
• W2801858894 hasAuthorship W2801858894A5019366279 @default.
• W2801858894 hasAuthorship W2801858894A5033513252 @default.
• W2801858894 hasAuthorship W2801858894A5036760030 @default.
• W2801858894 hasAuthorship W2801858894A5051508940 @default.
• W2801858894 hasAuthorship W2801858894A5060100321 @default.
• W2801858894 hasAuthorship W2801858894A5066416832 @default.
• W2801858894 hasAuthorship W2801858894A5076261158 @default.
• W2801858894 hasAuthorship W2801858894A5079717318 @default.
• W2801858894 hasAuthorship W2801858894A5088848843 @default.
• W2801858894 hasAuthorship W2801858894A5091716304 @default.
• W2801858894 hasBestOaLocation W28018588941 @default.
• W2801858894 hasConcept C121608353 @default.
• W2801858894 hasConcept C126322002 @default.
• W2801858894 hasConcept C141071460 @default.
• W2801858894 hasConcept C143998085 @default.
• W2801858894 hasConcept C2777658100 @default.
• W2801858894 hasConcept C2778164965 @default.
• W2801858894 hasConcept C2778871575 @default.
• W2801858894 hasConcept C2779013556 @default.
• W2801858894 hasConcept C2780140570 @default.
• W2801858894 hasConcept C2780387249 @default.
• W2801858894 hasConcept C502942594 @default.
• W2801858894 hasConcept C509974204 @default.
• W2801858894 hasConcept C71924100 @default.
• W2801858894 hasConceptScore W2801858894C121608353 @default.
• W2801858894 hasConceptScore W2801858894C126322002 @default.
• W2801858894 hasConceptScore W2801858894C141071460 @default.
• W2801858894 hasConceptScore W2801858894C143998085 @default.
• W2801858894 hasConceptScore W2801858894C2777658100 @default.
• W2801858894 hasConceptScore W2801858894C2778164965 @default.
• W2801858894 hasConceptScore W2801858894C2778871575 @default.
• W2801858894 hasConceptScore W2801858894C2779013556 @default.
• W2801858894 hasConceptScore W2801858894C2780140570 @default.
• W2801858894 hasConceptScore W2801858894C2780387249 @default.
• W2801858894 hasConceptScore W2801858894C502942594 @default.
• W2801858894 hasConceptScore W2801858894C509974204 @default.
• W2801858894 hasConceptScore W2801858894C71924100 @default.
• W2801858894 hasIssue "1" @default.
• W2801858894 hasLocation W28018588941 @default.

• next